Clear Lens Phacoemulsification in Alport Syndrome: Refractive Results and Electron Microscopic Analysis of The Anterior Lens Capsule

dc.contributor.authorBayar, Sezin Akca
dc.contributor.authorPinarci, Eylem Yaman
dc.contributor.authorKarabay, Gulten
dc.contributor.authorAkman, Ahmet
dc.contributor.authorOto, Sibel
dc.contributor.authorYilmaz, Gursel
dc.contributor.orcIDhttps://orcid.org/0000-0001-5109-755Xen_US
dc.contributor.orcIDhttps://orcid.org/0000-0003-0171-4200en_US
dc.contributor.orcIDhttps://orcid.org/0000-0002-2589-7294en_US
dc.contributor.pubmedID24170525en_US
dc.contributor.researcherIDAAJ-2406-2021en_US
dc.contributor.researcherIDAAJ-4668-2021en_US
dc.contributor.researcherIDAAK-6987-2021en_US
dc.date.accessioned2024-02-14T10:41:43Z
dc.date.available2024-02-14T10:41:43Z
dc.date.issued2014
dc.description.abstractPurpose: To report the ocular findings of patients with Alport syndrome and the results of clear lens extraction in this patient group. Methods: Twenty-three eyes of 15 patients with a diagnosis of Alport syndrome were included in this study. Clear corneal phacoemulsification and intraocular foldable lens implantation was performed in eyes with indeterminate refractive errors and/or poor visual acuity and anterior capsule samples were analyzed with electron microscopy. Results: All patients had a history of hereditary nephritis and/or deafness as systemic involvement. Ophthalmologic examination revealed anterior lenticonus with high myopia and/or irregular astigmatism in all patients. The mean best-corrected visual acuity (BCVA) was 0.67 +/- 0.17 logMAR (range 1.0-0.4) preoperatively and 0.17 +/- 0.08 logMAR (range 0.3-0.0) postoperatively. Postoperative refractive lenticular astigmatism dramatically decreased and no ocular complications arose during the follow-up period. Transmission electron microscopic analysis of the lens capsules supported the diagnosis of Alport syndrome. Conclusions: Clear lens phacoemulsification and foldable intraocular lens implantation is a safe and effective therapeutic choice for the management of uncorrectable refractive errors and low visual acuity due to anterior lenticonus in patients with Alport syndrome.en_US
dc.identifier.endpage351en_US
dc.identifier.issn1120-6721en_US
dc.identifier.issue3en_US
dc.identifier.startpage345en_US
dc.identifier.urihttp://hdl.handle.net/11727/11519
dc.identifier.volume24en_US
dc.identifier.wos000337652600009en_US
dc.language.isoengen_US
dc.relation.isversionof10.5301/ejo.5000365en_US
dc.relation.journalEUROPEAN JOURNAL OF OPHTHALMOLOGYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAlport syndromeen_US
dc.subjectAnterior lenticonusen_US
dc.subjectClear corneal phacoemulsificationen_US
dc.subjectElectron microscopic analysisen_US
dc.titleClear Lens Phacoemulsification in Alport Syndrome: Refractive Results and Electron Microscopic Analysis of The Anterior Lens Capsuleen_US
dc.typearticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: